Estimating pharmacokinetic parameters from Dynamic Contrast-Enhanced T ₁-weighted MRI using a three level hierarchical Bayesian model

References

[1] H. J. W. L. Aerts, N. A. W. van Riel and W. H. Backes, System identification theory in pharmacokinetic modeling of Dynamic Contrast-Enhanced MRI: Influence of contrast injection, Magn. Reson. Med. 59 (2008), 1111–1119. 10.1002/mrm.21575Search in Google Scholar PubMed

[2] P. Armitage, C. Behrenbruch, M. Brady and N. Moore, Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast, Med. Image. Anal. 9 (2005), no. 4, 315–329. 10.1016/j.media.2005.01.001Search in Google Scholar PubMed

[3] M. P. Aryal, T. N. Nagaraja, K. A. Keenan, H. Bagher-Ebadian, S. Panda, S. L. Brown, G. Cabral, J. D. Fenstermacher and J. R. Ewing, Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T, Magn. Reson. Med. 71 (2014), 2206–2214. 10.1002/mrm.24873Search in Google Scholar PubMed PubMed Central

[4] T. Barrett, A. B. Gill, M. Y. Kataoka, A. N. Priest, I. Joubert, M. A. McLean, M. J. Graves, S. Stearn, D. J. Lomas, J. R. Griffiths, D. Neal, V. J. Gnanapragasam and E. Sala, DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: A feasibility study, Magn. Reson. Med. 67 (2012), no. 3, 778–785. 10.1002/mrm.23062Search in Google Scholar PubMed

[5] J. E. Bennett, A. Racine-Poon and J. C. Wakefield, MCMC for nonlinear hierarchical models, Markov Chain Monte Carlo in Practice, Chapman and Hall, London (1996), 337–339. Search in Google Scholar

[6] R. M. Berman, A. M. Brown, S. D. Chang, S. Sankineni, M. Kadakia, B. J. Wood, P. A. Pinto, P. L. Choyke and B. Turkbey, DCE MRI of prostate cancer, Abdom. Radiol. (NY) 41 (2016), 844–853. 10.1007/s00261-015-0589-3Search in Google Scholar PubMed PubMed Central

[7] N. Betrouni and G. Tartare, ProstateAtlas SimDCE: A simulation tool for dynamic contrast enhanced imaging of prostate, IRBM 36 (2015), no. 3, 166–169. 10.1016/j.irbm.2015.01.015Search in Google Scholar

[8] J. Chen, J. Yao and D. Thomasson, Automatic determination of arterial input function for dynamic contrast enhanced MRI in tumor assessment, Med. Image. Comput. Comput. Assist. Interv. 11 (2008), 594–601. 10.1007/978-3-540-85988-8_71Search in Google Scholar PubMed PubMed Central

[9] E. Cho, D. J. Chung, D. M. Yeo, D. Sohn, Y. Son, T. Kim and S.-T. Hahn, Optimal cut-off value of perfusion parameters for diagnosing prostate cancer and for assessing aggressiveness associated with Gleason score, Clinical Imag. 39 (2015), 834–840. 10.1016/j.clinimag.2015.04.020Search in Google Scholar PubMed

[10] C. A. Cuenod and D. Balvay, Imagerie de la perfusion tissulaire et de la perméabilité, J. Radiol. Diagn. Interv. 94 (2013), 1184–1202. 10.1016/j.jradio.2013.08.011Search in Google Scholar

[11] A. H. El Beltagi, A. H. Elsotouhy, A. M. Own, W. Abdelfattah, K. Nair and S. Vattoth, Functional magnetic resonance imaging of head and neck cancer: Performance and potential, Neuroradiology 32 (2019), 36–52. 10.1177/1971400918808546Search in Google Scholar PubMed PubMed Central

[12] A. Fabijanska, A novel approach for quantification of time-intensity curves in a DCE-MRI image series with an application to prostate cancer, Comput. Biol. Med. 73 (2016), 119–130. 10.1016/j.compbiomed.2016.04.010Search in Google Scholar PubMed

[13] F. Fornasa, Diffusion-weighted magnetic resonance imaging: What makes water run fast or slow?, J. Clinical Imag. Sci. 1 (2011), no. 2, 1–7. 10.4103/2156-7514.81294Search in Google Scholar PubMed PubMed Central

[14] A. E. Gelfand and A. F. M. Smith, Sampling-based approaches to calculating marginal densities, J. Amer. Statist. Assoc. 85 (1990), 398–409. 10.1080/01621459.1990.10476213Search in Google Scholar

[15] A. Gelman, J. B. Carlin, H. S. Stern, D. B. Dunson, A. Vehtari and D. B. Rubin, Bayesian Data Analysis, 3rd ed., Chapman and Hall/CRC, New York, 2013. 10.1201/b16018Search in Google Scholar

[16] S. Guljas̆, M. Bens̆ić, Z. K. Dupan, O. Pavloviić, V. Krajina, D. Pavokoviić, P. Takaic̆, M. Hrani and T. Salha, Dynamic Contrast Enhanced study in multiparametric examination of the prostate–Can we make better use of it?, Tomography 8 (2022), 1509–1521. 10.3390/tomography8030124Search in Google Scholar PubMed PubMed Central

[17] S. Isebaert, F. De Keyzer, K. Haustermans, E. Lerut, T. Roskams, I. Roebben, H. V. Poppel, S. Joniau and R. Oyen, Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount, histopathology, Eur. J. Radiol. 81 (2012), e217–e222. 10.1016/j.ejrad.2011.01.107Search in Google Scholar PubMed

[18] P. Kozlowski, S. D. Chang, R. Meng, B. Mädler, R. Bell, E. C. Jones and S. Larry Goldenberg, Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T-quantitative correlation with biopsy, J. Magn. Reson. Imag. 28 (2010), no. 5, 621–628. 10.1016/j.mri.2010.03.011Search in Google Scholar PubMed PubMed Central

[19] C. K. Kuhl, P. Mielcareck, S. Klaschik, C. Leutner, E. Wardelmann, J. Gieseke and H. H. Schild, Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?, Radiology 211 (1999), 101–110. 10.1148/radiology.211.1.r99ap38101Search in Google Scholar PubMed

[20] J. Pintaske, P. Martirosian, H. Graf, G. Erb, K-P. Lodemann, C. D. Claussen and F. Schick, Relaxivity of gadopentetate dimeglumine (magnevist), gadobutrol (gadovist), and gadobenate dimeglumine (multiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla, Invest. Radiol. 41 (2006), 213–221. 10.1097/01.rli.0000197668.44926.f7Search in Google Scholar PubMed

[21] M. Plummer, Simulation-based Bayesian analysis, Annu. Rev. Stat. Appl. 10 (2023), 401–425. 10.1146/annurev-statistics-122121-040905Search in Google Scholar

[22] P. Puech, A. Sufana Iancu, B. Renard, A. Villers and L. Lemaitre, Detecting prostate cancer with MRI: Why and how, Diagn. Interv. Imag. 93 (2012), 268–278. 10.1016/j.diii.2012.01.019Search in Google Scholar

[23] R. Sanz-Requena, J. M. Prats-Montalbán, L. Martí-Bonmatí, A. Alberich-Bayarri, G. Garíca-Martí, R. Pérez and A. Ferrer, Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images, J. Magn. Reson. Imag. 42 (2015), no. 2, 477–487. 10.1002/jmri.24805Search in Google Scholar

[24] N. Schieda, C. S. Lim, F. Zabihollahy, J. Abreu-Gomez, S. Krishna, S. Woo, G. Melkus, E. Ukwatta and B. Turkbey, Quantitative prostate MRI, J. Magn. Reson. Imag. 53 (2020), 1632–1645. 10.1002/jmri.27191Search in Google Scholar

[25] A. Shukla-Dave, N. A. Obuchowski, T. L. Chenevert, S. Jambawalikar, L. H. Schwartz, D. Malyarenko, W. Huang, S. M. Noworolski, R. J. Young, M. S. Shiroishi, H. Kim, C. Coolens, H. Laue, C. Chung, M. Rosen, M. Boss and E. F. Jackson, Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of dwi and dce-mri derived biomarkers in multicenter oncology trials, J. Magn. Reson. Imag. 49 (2019), no. 7, e101–e121. 10.1002/jmri.26805Search in Google Scholar

[26] S. P. Sourbron and D. L. Buckley, On the scope and interpretation of the Tofts models for DCE MRI, Magn. Reson. Med. 66 (2011), 735–745. 10.1002/mrm.22861Search in Google Scholar

[27] S. P. Sourbron and D. L. Buckley, Tracer kinetic modeling in MRI: Estimating perfusion and capillary permeability, Phys. Med. Biol. 57 (2012), R1–R33. 10.1088/0031-9155/57/2/R1Search in Google Scholar

[28] N. Sushentsev, L. Rundo, O. Blyuss, V. J. Gnanapragasam, E. Sala and T. Barrett, MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance, Sci. Rep. 11 (2021), Article ID 12917. 10.1038/s41598-021-92341-6Search in Google Scholar

[29] P. S. Tofts, Modeling tracer kinetics in dynamic Gd-DTPA MR imaging, J. Magn. Reson. Imag. 7 (1997), 91–101. 10.1002/jmri.1880070113Search in Google Scholar

[30] P. S. Tofts and A. G. Kermode, Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts, Magn. Reson. Med. 17 (1991), 357–367. 10.1002/mrm.1910170208Search in Google Scholar

[31] P. S. Tofts, G. Brix, D. L. Buckley, J. L. Evelhoch, E. Henderson, M. V. Knopp, H. B. W. Larsson, T-Y. Lee, N. A. Mayr, G. J. M. Parker, R. E. Port, J. Taylor and R. M. Weisskoff, Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols, J. Magn. Reson. Imag. 10 (1999), 223–232. 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-SSearch in Google Scholar

[32] S. Verma, B. Turkbey, N. Muradyan, A. Rajesh, F. Cornud, M. A. Haider, P. L. Choyke and M. Harisinghani, Overview of Dynamic Contrast Enhanced MRI in prostate cancer diagnosis and management, AJR Am. J. Roentgenol. 198 (2012), 1277–1288. 10.2214/AJR.12.8510Search in Google Scholar PubMed PubMed Central

[33] J. C. Wakefield, The Bayesian analysis of population pharmacokinetic models, J. Amer. Statist. Assoc. 91 (1996), 62–75. 10.1080/01621459.1996.10476664Search in Google Scholar

[34] J. C. Wakefield, L. Aarons and A. Racine-Poon, The Bayesian approach to population pharmacokinetic/pharmacodynamic modeling, Case Studies in Bayesian Statistics, Springer, New York (1999), 205–265. 10.1007/978-1-4612-1502-8_4Search in Google Scholar

[35] C. Wei, B. Bowen Jin, M. Szewczyk-Bieda, S. Gandy, S. Lang, Y. Zhang, Z. Huang and G. Nabi, Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterization of prostate cancer, Oncotarget 9 (2018), no. 22, 15997–16007. 10.18632/oncotarget.24652Search in Google Scholar PubMed PubMed Central

[36] H. J. Weinmann, M. Laniado and W. Mutzel, Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers, Phys. Chem. Phys. Med. NMR. 16 (1984), no. 2, 167–172. Search in Google Scholar

[37] T. E. Yankeelov and J. C. Gore, Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples, Curr. Med. Imaging Rev. 3 (2009), 91–107. 10.2174/157340507780619179Search in Google Scholar PubMed PubMed Central

[38] American Cancer Society, 2019, available at https://www.cancer.org/cancer/, accessed on 23 March 2023. Search in Google Scholar

[39] QIBA Profile: DCE-MRI Quantification (DCEMRI-Q), 2017, http://qibawiki.rsna.org/images/1/1f/QIBA_DCE-MRI_Profile-Stage_1-Public_Comment.pdf, accessed on 16 January 2022. Search in Google Scholar

[40] World Health Organization. Cancer fact sheets: Prostate cancer, 2012, available at https://gco.iarc.fr/today/data/pdf/fact-sheets/cancers/cancer-fact-sheets-19.pdf, accessed on 23 March 2023. Search in Google Scholar